AbbVie Inc.
ABBV.BA
Get informed when a big investor buys or sells
+ FollowMarket Cap$464.35B
Close$
Share Statistics
| Market cap | $464.35 Billion |
|---|---|
| Enterprise Value | $528.60 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -106.49% |
|---|---|
| Return on Assets | 4.68% |
| Return on Invested Capital | 17.29% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.21 |
| Enterprise Value to EBIT | 32.71 |
| Enterprise Value to Net Income | 83 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | -11.93 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Abbvie Inc
57,000 employees
CEO: Richard Gonzalez AbbVie Inc. operates as a global pharmaceutical enterprise, concentrating on the discovery, development, production, and commercialization of medicinal products across the world. Its extensive product portfolio addresses various therapeu...